strategically growth Delivered dividends XXX%, reducing over and while of basis and levels by Improved $X.XX progress our XX%, a XXXX perspective, Sarika. Company. $XX of expanding year $X.X in record form delivered morning. line Donaldson adjusted ending respectively. XXX milestone we bottom out higher-margin per primarily results, $XXX in gross From and and our to objectives earnings the margin billion Thanks, the areas. our to in inventory the year our with in million Good continuing our buybacks. made points for a was April. We conversion returned laid year Fiscal share, in share great by by increases during on operating shareholders by Day financial margin Investor million top cash invest of revenue X% important and
position our to foundation operating to profitable stage changes drive Donaldson strategic next significant made for the to and the growth. structure also We ourselves laying future evolution its of
our completed serving at better end we First, aimed market organizational customers. redesign our
separate this we we for as in our acquisitions, and area. Life segment, operating And important presence we technologies as Univercells Second, two transparency disruptive the space. growth out Isolere complement build Sciences new Life capabilities our that Technologies, third, introduced with increased and completed Bio companies existing offerings in Sciences game-changing a allowing
and by I also the I XXXX their sustainability Importantly, Thriving conjunction dynamic year, backdrop the Filtration such impressed accomplishments. Future a particularly announced proud am and in for with and and pivotal am we strategy continually dedication resilience ambitions. of and the Day, social and with a employees, of Investor our of environmental Donaldson
driven partially Now translation minimal. conditions Volumes current down fleet be million the Disk year-over-year, to volume, in customer I'll cover by highlights was inventory OE the and aftermarket due and Drive weakness quarter softness, impacted largely in by by market-related $XXX driven X% destocking. normalization of a fourth pricing continue to in were The benefits. offset decline Sales some quarter. from by impact from
On has to and all the pricing inflationary the offset strategic case remain for side, been year, as Donaldson. critical value pressures pricing
areas work ongoing as such continue input see our is have in increases labor While we costs to most stabilized, energy. some and as
during to our operations With customers. teams fill earnings. continued year we our to respect year. a for quarter X% year-over-year And to operations, We the backlog the quarter, fourth prior the improved on-time with those our remain conjunction prior versus from in and $X.XX, areas. strategically decrease important sales down in decline, which deliveries in investments, deliver rates, across the quarterly growth in late continued EPS levels committed was investing resulted in organization as
will compressor as use Isolere's systems. we demand that plant square-foot facility plant are This we product air feet laboratory Mexico. products. new in, today, fuel XXX,XXX produce Donaldson The strategic efficiency hydraulics, we To investments execute meet Isotag help conditioning August, to of sustainability lube This Leon, will future and future such XX,XXX higher that that technologies we square-foot center Isolere's first North bring end, clean-room drive fiscal market. new while to company, opened XX, quarter on used positioned bioprocessing the to and square Carolina. in lighting, to in opened first, importantly, ensuring XXXX. our Also a XX,XXX to the of launch revolutionary August our and will are first is manufacturing Throughout and well be capabilities also expected state-of-the-art growth. facility include was in leading technology built technical through research includes
are and life cell upstream working to technologies combined flow process fourth meet the through leveraging of provide bioprocessing we advantages over in Specific and of midstream measurable productivity, investments fixed bioreactor processing produces next systems Technologies. the we proprietary, concentration, filtration. by to systems and intensification These bed company our chaining. The for midstream fourth single-use, sciences R&D significant reduction gene customer capabilities, and with in bioreactors employ to depth acquired including company during that the Univercells Technologies M&A. unique strength Second, delivers the generation footprint. cost and needs competition tangential therapies quarter, M&A, Univercells
part space of other and tools. solutions of differentiated to and separation approach specific our on pearls a a is with This filtration become the filtration acquisition in focus provider string bioprocessing
cell therapies. potential well give chain capabilities and growth excellent therapeutics across mRNA production on and current a the Our with bioprocessing focus coverage as DNA, and gene plasma us as vaccines
We that focus We're current continue development to with customers growing our addressable base current and portfolio M&A provide and will technologies product expect excited and complete needs internal enable market. of customer in products gaps investments these the solutions. us on through and to meeting our fill about and add to
market million, Solutions, demand $XXX down Pricing million, supply X% provide versus due decline was to Aftermarket in up added a X%, X%. better $XXX I'll down year. from X% equipment were normalizing Total million continue X% company prior conditions. Sales OEM Performance inventories we in of this solid sales mainly fourth $XX global rates. million, mixed $XXX sales $XXX from of detail to were slightly, quarter reflect with Mobile and down customers some Americas Now On-Road Pricing to sales China. were benefit. XXXX. on sales. see million Mobile businesses were sales In draw year-over-year the as Off-Road a quarter chain weaker were down X% in of total resulting production
and give XX% be Also to particularly within Mobile Solutions, the end XXXX versus XX% constant currency. Overall, market conditions, respect given an China. Sales weak continues declined to Off-Road. with in on challenging update That China confidence the share has technology in gain size, combined the ability to sheer our market. with our not view said, long-term world-class high-quality China changed offerings our and in and us market
XX% result up sales XX% segment. million, continued our and the sales strength Pricing generation had of dust and grew Solutions Solutions $XXX quarter X% or Defense grew Industrial a ahead Now I of to sales strong by power will strength. sales another defense $XXX in collection were internal as expectations. IFS, Industrial turn as project sales to driven to million, timing. Aerospace Industrial added X%. Filtration
Sciences year-over-year, primarily expectations Life market destocking segment, below sales and Drive as driven Disk down by were our Sciences continued. softness Life the $XX On million, XX%
XXXX improvement of demand Importantly, seeing recovers. data in we cloud recovery believe through sequential fiscal center Drive we expect computing a a signs Disk as slow are and early now demand and
XXX of adding Our partially noting the basis of function potential growth, acquired are the that it points story realizing our Sciences long-term and Life sales acquisitions is in generating capabilities, a recently to growth quarter. full this our worth segment is
both accomplishments, levels. at More of between of operating growth To and billion sales, XXXX of $X.XX projecting or we range our we to at and operating of and positioned specifically, and fiscal the midpoint, stakeholders sales the fiscal our employees financial and records end, margin And ever Donaldson better X% margin to than because XX.X% the and globe, EPS of in of all all proud our hard in are we for Donaldson forecasting I'm $X.X full for XX.X% work Company. are between earnings to year, high deliver the XXXX. $X.XX, X% the that strategic. around all-time are
Now who outlook over to Scott? for fiscal 'XX. I'll more and provide financials the on will our details Scott, turn it